Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Martinez R."" wg kryterium: Autor


Tytuł:
HEARTS in the Americas: Targeting Health System Change to Improve Population Hypertension Control.
Autorzy:
Ordunez P; Department of Non-Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA. .
Campbell NRC; Department of Medicine, Libin Cardiovascular Institute, The University of Calgary, Calgary, AB, T2N 1N4, Canada.
DiPette DJ; University of South Carolina and University of South Carolina School of Medicine, Columbia, SC, USA.
Jaffe MG; Department of Endocrinology, The Permanente Medical Group, Kaiser San Francisco Medical Center, San Francisco, CA, USA.
Rosende A; Department of Non-Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.
Martinez R; Department of Non-Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.
Gamarra A; Department of Non-Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.
Lombardi C; Department of Non-Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.
Parra N; Department of Non-Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.
Rodriguez L; Department of Non-Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.
Rodriguez Y; Department of Non-Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.
Brettler J; Southern California Permanente Medical Group, Department of Health Systems Science, Regional Hypertension Program, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, USA.
Pokaż więcej
Źródło:
Current hypertension reports [Curr Hypertens Rep] 2024 Apr; Vol. 26 (4), pp. 141-156. Date of Electronic Publication: 2023 Dec 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hypertension*/drug therapy
Hypertension*/epidemiology
Hypertension*/prevention & control
Humans ; Delivery of Health Care
Czasopismo naukowe
Tytuł:
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach.
Autorzy:
Hernandez S; From the Department of Pathology, 12 de Octubre University Hospital, Research Institute 12 de Octubre University Hospital (i+12), Madrid, Spain (Hernandez, Alonso).
Conde E; the Department of Pathology, 12 de Octubre University Hospital, Universidad Complutense de Madrid, Research Institute 12 de Octubre University Hospital (i+12), CIBERONC, Madrid, Spain (Conde, Lopez-Rios).
Molero A; the Department of Pathology, Segovia General Hospital, Segovia, Spain (Molero).
Suarez-Gauthier A; the Department of Pathology, Jimenez Diaz Foundation University Hospital, Madrid, Spain (Suarez-Gauthier).
Martinez R; the Department of Pathology, Health Diagnostic-Grupo Quiron Salud, Madrid, Spain (Martinez).
Alonso M; From the Department of Pathology, 12 de Octubre University Hospital, Research Institute 12 de Octubre University Hospital (i+12), Madrid, Spain (Hernandez, Alonso).
Plaza C; the Department of Pathology, Clinico San Carlos University Hospital, Madrid, Spain (Plaza).
Camacho C; the Department of Pathology, Insular Materno-Infantil University Hospital, Las Palmas de Gran Canaria, Spain (Camacho).
Chantada D; the Department of Pathology, Alvaro Cunqueiro Hospital, Vigo, Spain (Chantada, Juaneda-Magdalena).
Juaneda-Magdalena L; the Department of Pathology, Alvaro Cunqueiro Hospital, Vigo, Spain (Chantada, Juaneda-Magdalena).
Garcia-Toro E; the Department of Pathology, Burgos University Hospital, Burgos, Spain (Garcia-Toro, Saiz-Lopez).
Saiz-Lopez P; the Department of Pathology, Burgos University Hospital, Burgos, Spain (Garcia-Toro, Saiz-Lopez).
Rojo F; the Institute of Health Research-Jimenez Diaz Foundation, CIBERONC, Madrid, Spain (Rojo).
Abad M; the Department of Pathology, Salamanca University Hospital, Salamanca, Spain (Abad).
Boni V; NEXT Oncology Madrid, Quiron Salud Madrid University Hospital, Madrid, Spain (Boni).
Del Carmen S; the Department of Pathology, Marques de Valdecilla University Hospital, Santander, Spain (del Carmen).
Regojo RM; the Department of Pathology, La Paz University Hospital, Madrid, Spain (Regojo).
Sanchez-Frias ME; the Department of Pathology, Reina Sofia University Hospital, Cordoba, Spain (Sanchez-Frias).
Teixido C; the Department of Pathology, Thoracic Oncology Unit, Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain (Teixido).
Paz-Ares L; the Department of Oncology, 12 de Octubre University Hospital, Department of Medicine, Universidad Complutense de Madrid, Research Institute 12 de Octubre University Hospital (i+12), CIBERONC, Madrid, Spain (Paz-Ares).
Lopez-Rios F; the Department of Pathology, 12 de Octubre University Hospital, Universidad Complutense de Madrid, Research Institute 12 de Octubre University Hospital (i+12), CIBERONC, Madrid, Spain (Conde, Lopez-Rios).
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Mar 01; Vol. 148 (3), pp. 318-326.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms*/diagnosis
Neoplasms*/genetics
Neoplasms*/pathology
Breast Neoplasms*
Carcinoma*
Humans ; Female ; Receptor, trkA/genetics ; Genomics ; Oncogene Proteins, Fusion/genetics
Czasopismo naukowe
Tytuł:
Relative Body Mass Index Improves the BMI Percentile Performance for Detection and Monitoring of Excess Adiposity in Adolescents.
Autorzy:
Velasquez-Mieyer PA; Lifedoc Health, 6625 Lenox Park Drive, Suite 205, Memphis, TN 38115, USA.; Lifedoc Research, 6625 Lenox Park Drive, Suite 205, Memphis, TN 38115, USA.
Nieto-Martinez R; Lifedoc Health, 6625 Lenox Park Drive, Suite 205, Memphis, TN 38115, USA.; Departments of Global Health and Population and Epidemiology, Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.
Neira CP; Lifedoc Health, 6625 Lenox Park Drive, Suite 205, Memphis, TN 38115, USA.; Lifedoc Research, 6625 Lenox Park Drive, Suite 205, Memphis, TN 38115, USA.
De Oliveira-Gomes D; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Velasquez Rodriguez AE; Lifedoc Research, 6625 Lenox Park Drive, Suite 205, Memphis, TN 38115, USA.
Ugel E; Departments of Global Health and Population and Epidemiology, Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.
Cowan PA; College of Nursing, University of Arkansas for Medical Science, Little Rock, AR 72205, USA.
Pokaż więcej
Źródło:
Nutrients [Nutrients] 2024 Feb 29; Vol. 16 (5). Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Adiposity*
Overweight*/metabolism
Male ; Female ; Adolescent ; Humans ; Body Mass Index ; Obesity/metabolism ; Adipose Tissue/metabolism ; Absorptiometry, Photon ; Body Composition
Czasopismo naukowe
Tytuł:
Catastrophic Streptococcus pyogenes Disease: A Personalized Approach Based on Phenotypes and Treatable Traits.
Autorzy:
Ruiz-Rodríguez JC; Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Departament of Medicine, Universitat Autonoma de Barcelona, 08193 Barcelona, Spain.
Chiscano-Camón L; Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Departament of Medicine, Universitat Autonoma de Barcelona, 08193 Barcelona, Spain.
Maldonado C; Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Ruiz-Sanmartin A; Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Martin L; Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Bajaña I; Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Bastidas J; Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Lopez-Martinez R; Immunology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Franco-Jarava C; Immunology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
González-López JJ; Microbiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Ribas V; Eurecat, Centre Tecnològic de Catalunya, EHealth Unit, 08005 Barcelona, Spain.
Larrosa N; Microbiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Riera J; Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Nuvials-Casals X; Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Ferrer R; Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Departament of Medicine, Universitat Autonoma de Barcelona, 08193 Barcelona, Spain.
Pokaż więcej
Źródło:
Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2024 Feb 15; Vol. 13 (2). Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies